Literature DB >> 9627163

Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori.

A Archimandritis1, S Souyioultzis, M Katsorida, M Tzivras.   

Abstract

We describe a 54-year-old man with Helicobacter pylori (+) duodenal ulcer who developed Clostridium difficile associated colitis, 5 days after commencing a 'triple' regimen consisting of omeprazole 20 mg b.d., metronidazole 500 mg b.d. and clarithromycin 500 mg b.d., to eradicate H. pylori. Despite the fact that oral metronidazole did not prevent the disease, the patient did well after treatment with oral metronidazole plus a yeast preparation (Saccharomyces bulardii). No relapse occurred.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627163     DOI: 10.1046/j.1365-2796.1998.00272.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

Review 1.  How should Helicobacter pylori infected children be managed?

Authors:  M Rowland; C Imrie; B Bourke; B Drumm
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 2.  Clostridium difficile Infection: An Epidemiology Update.

Authors:  Ana C De Roo; Scott E Regenbogen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

3.  Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.

Authors:  Anca Trifan; Irina Girleanu; Camelia Cojocariu; Catalin Sfarti; Ana Maria Singeap; Carmen Dorobat; Lucia Grigore; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

4.  Do we eradicate Helicobacter pylori in hospitalized patients with peptic ulcer disease?

Authors:  Frank Wong; George Ou; Sigrid Svarta; Ricky Kwok; Kieran Donaldson; Joe Frenette; Robert Enns
Journal:  Can J Gastroenterol       Date:  2013-09-13       Impact factor: 3.522

5.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

6.  Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection.

Authors:  Yi-Qi Du; Tun Su; Jian-Gao Fan; Yu-Xia Lu; Ping Zheng; Xing-Hua Li; Chuan-Yong Guo; Ping Xu; Yan-Fang Gong; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

7.  Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

Review 8.  Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.

Authors:  Yuan-Pin Hung; Jen-Chieh Lee; Hsiao-Ju Lin; Hsiao-Chieh Liu; Yi-Hui Wu; Pei-Jane Tsai; Wen-Chien Ko
Journal:  Antibiotics (Basel)       Date:  2015-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.